Buy Lamivudine-stavudine generic, Cheap Lamivudine+stavudine online

Each Uncoated Tablet Contains(Lamivudine 150mg+Stavudine 30mg) :

Satvudine 30mg
Lamivudine 150mg

Each Uncoated Tablet Contains (Lamivudine 150mg+Stavudine 40mg) :


Satvudine 40mg
Lamivudine 150mg


Each Combination Tablet contains half of the commonly prescribed daily doses of both stavudine and lamivudine. With the availibility of this combination tablet patients maybe better able to adhere to complex drug treatmen regimens, thereby enhancing complaince.

Recommended Dose:

Adults : For patients weighing <60 Kgs Take Lamivudine 150mg + Stavudine 30mg, 1 Tablet, Twice daily.

Adults : For patients weighing >=60 Kgs Take Lamivudine 150mg + Stavudine 40mg, 1 Tablet, Twice daily.

Please consult your health care professional before taking this combination and take exactly as prescribed. As this is a fixed dose combination, this medication should not be prescribed for patients requiring dosage adjustment, such as those with reduced renal function, those with low body weight(<50 Kgs or 110lb), or those experiencing dose limiting adverse events.

Stavudine therapy has rarely been associated with motor weakness, occuring predominantly in the setting of lactic acidosis. If motor weakness develops or the patient is suspected with lactic acidosis, immediately suspend therapy with stavudine. Permanent discontinuation should be considered for patients with confirmed lactic acidosis.

Stavudine therapy has also been associated with peripheral sensory neuropathy, which can be severe, is dose related, and occurs more frequently in patients being treated with neurotoxic drug therapy, including didanosine, in patients with advanced HIV infection, or in patients who have previously experienced peripheral neuropathy.

Patients should be monitored for the development of neuropathy. Stavudine related neuropathy may resolve is therapy is withdrawn promptly, in some cases symptoms may worsen temporarily following the discontinuation of therapy. If symptoms resolve completely, patients may tolerate resumption of treatment at one half of the dose, If neuropathy recurs thereafter, discontinuation of stavudine should be considered.